BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26208914)

  • 1. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
    Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
    Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
    Jordan C; Li HH; Kwan HC; Francke U
    BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
    Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
    Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
    Mol Autism; 2017; 8():56. PubMed ID: 29090078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model.
    Petazzi P; Sandoval J; Szczesna K; Jorge OC; Roa L; Sayols S; Gomez A; Huertas D; Esteller M
    RNA Biol; 2013 Jul; 10(7):1197-203. PubMed ID: 23611944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
    Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
    Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling.
    Vacca M; Tripathi KP; Speranza L; Aiese Cigliano R; Scalabrì F; Marracino F; Madonna M; Sanseverino W; Perrone-Capano C; Guarracino MR; D'Esposito M
    BMC Bioinformatics; 2016 Jan; 17 Suppl 2(Suppl 2):14. PubMed ID: 26821710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.
    Maezawa I; Swanberg S; Harvey D; LaSalle JM; Jin LW
    J Neurosci; 2009 Apr; 29(16):5051-61. PubMed ID: 19386901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.
    Roux JC; Zala D; Panayotis N; Borges-Correia A; Saudou F; Villard L
    Neurobiol Dis; 2012 Feb; 45(2):786-95. PubMed ID: 22127389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
    Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
    PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 deficiency is associated with impaired microtubule stability.
    Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
    FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
    Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
    J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.
    Zhao D; Mokhtari R; Pedrosa E; Birnbaum R; Zheng D; Lachman HM
    Mol Autism; 2017; 8():17. PubMed ID: 28367307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients.
    Delgado IJ; Kim DS; Thatcher KN; LaSalle JM; Van den Veyver IB
    BMC Med Genet; 2006 Jul; 7():61. PubMed ID: 16859563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.
    Tudor M; Akbarian S; Chen RZ; Jaenisch R
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15536-41. PubMed ID: 12432090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytic modulation of excitatory synaptic signaling in a mouse model of Rett syndrome.
    Rakela B; Brehm P; Mandel G
    Elife; 2018 Jan; 7():. PubMed ID: 29313799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 Deficiency Leads to Loss of Glial Kir4.1.
    Kahanovitch U; Cuddapah VA; Pacheco NL; Holt LM; Mulkey DK; Percy AK; Olsen ML
    eNeuro; 2018; 5(1):. PubMed ID: 29464197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.
    Ballas N; Lioy DT; Grunseich C; Mandel G
    Nat Neurosci; 2009 Mar; 12(3):311-7. PubMed ID: 19234456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
    Ribeiro MC; MacDonald JL
    Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type microglia arrest pathology in a mouse model of Rett syndrome.
    Derecki NC; Cronk JC; Lu Z; Xu E; Abbott SB; Guyenet PG; Kipnis J
    Nature; 2012 Mar; 484(7392):105-9. PubMed ID: 22425995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.